November 10: The Week in Cancer News
Sun exposure is an occupational hazard around the globe, and a dormant virus can cause immunotherapy complications.
Progress Against Cancer
Sun exposure is an occupational hazard around the globe, and a dormant virus can cause immunotherapy complications.
Cancers are driven by unique genetic alterations, so what if we targeted these alterations to treat the cancer? It seems straightforward, but it’s easier said than done.
New recommendation suggests ongoing lung cancer screening for those with heavy smoking history even after quitting, and more.
In the opening keynote session of the AACR Special Conference on Pancreatic Cancer, which took place September 27-30 in Boston, co-chair Jen Jen Yeh, MD, exemplified the excitement and passion exuding from the researchers...
For our readers who enjoy learning about the newest tools and strategies in cancer research, the second installment of our series, “From the Bench,” is here. (Check out the inaugural post here.) This quarter,...
As you prepare for trick-or-treating, check out the articles selected by the editors of the 10 AACR journals for the month of October. Highlights include studies on the regulation of electrical activity between melanoma...
In 2021, Lillian L. Siu, MD, and Elaine R. Mardis, PhD, FAACR, each received a call from AACR Chief Executive Officer Margaret Foti, PhD, MD (hc), asking if they’d be interested in serving as...
Immunotherapy drug approved as pre- and post-surgery treatment for non-small cell lung cancer, and bladder cancer patients who respond to chemotherapy and immunotherapy can forgo surgery.
Neuroblastoma, a rare cancer that occurs primarily in children, is a scientific paradox, said pediatric oncologist John M. Maris, MD, of Children’s Hospital of Philadelphia (CHOP). “On one hand, a fairly high percentage of...
Researchers share approaches for improving participation among underrepresented groups at AACR conference.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 54,000 members worldwide drive progress against cancer.
Donate Now